ENDONOVO THERAPEUTICS, INC. — Regulation A 1-A
ENDONOVO THERAPEUTICS, INC. of Woodland Hills, CA filed a Regulation A 1-A with the SEC on 2022-02-11. Aggregate offering: $5.0M (Tier 2). Industry: Other.
Offering
- Filed: 2022-02-11
- Form: 1-A
- Accession: 0001493152-22-004106
- Tier: Tier 2
- Total aggregate offering: $5.0M
- Issuer portion: $5.0M
- Price per security: $0.0250
- Securities offered: Equity (common or preferred stock)
- Underwriter: Dalmore Group, LLC
- Broker-dealer CRD: 136352
- Audit status: Audited
- Auditor: Rose, Snyder & Jacobs, LLP
- Jurisdictions: 52 states/territories
Issuer
- CIK: 0001528172
- Organized in: DE
- Incorporated: 2008
- Address: 6320 Canoga Avenue, Woodland Hills, CA, 91367
- Phone: 800-489-4774
Financial snapshot (as filed)
- Total assets: $2.6M
- Cash & equivalents: $13K
- Total liabilities: $17.0M
- Stockholder equity: $-14.4M
- Revenues: $166K
- Net income: $-396K
People (1)
| Name | Role | Location |
|---|
| Alan Collier Ceo | Signer | Woodland Hills, CA |
Other Reg A filings by this issuer (3)
More